☰

Subhamoy Dasgupta, Ph.D. - Publications

Affiliations: 
2010 Biomedical Sciences University of North Texas Health Science Center at Fort Worth 
Area:
Molecular Biology, Oncology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Singh R, Meng H, Shen T, Lumahan LEV, Nguyen S, Shen H, Dasgupta S, Qin L, Karri D, Zhu B, Yang F, Coarfa C, O'Malley BW, Yi P. TRAF4-mediated nonproteolytic ubiquitination of androgen receptor promotes castration-resistant prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 120: e2218229120. PMID 37155905 DOI: 10.1073/pnas.2218229120  0.413
2022 Dai T, Rosario SR, Katsuta E, Sawant Dessai A, Paterson EJ, Novickis AT, Cortes Gomez E, Zhu B, Liu S, Wang H, Abrams SI, Seshadri M, Bshara W, Dasgupta S. Hypoxic activation of PFKFB4 in breast tumor microenvironment shapes metabolic and cellular plasticity to accentuate metastatic competence. Cell Reports. 41: 111756. PMID 36476868 DOI: 10.1016/j.celrep.2022.111756  0.352
2020 Sawant Dessai A, Palestino Dominguez M, Chen UI, Hasper J, Prechtl C, Yu C, Katsuta E, Dai T, Zhu B, Jung SY, Putluri N, Takabe K, Zhang XH, O'Malley BW, Dasgupta S. Transcriptional repression of SIRT3 potentiates mitochondrial aconitase activation to drive aggressive prostate cancer to the bone. Cancer Research. PMID 33115805 DOI: 10.1158/0008-5472.CAN-20-1708  0.494
2020 Dominguez MP, Dessai AS, Katsuta E, Dai T, Dasgupta S. Abstract 4706: Transcriptional repression of mitochondrial deacetylase SIRT3 promotes prostate cancer metastasis Cancer Research. 80: 4706-4706. DOI: 10.1158/1538-7445.Am2020-4706  0.578
2019 Katsuta E, Yan L, Takeshita T, McDonald KA, Dasgupta S, Opyrchal M, Takabe K. High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 21. PMID 31905596 DOI: 10.3390/Ijms21010217  0.338
2019 Takahashi H, Katsuta E, Yan L, Dasgupta S, Takabe K. High expression of Annexin A2 is associated with DNA repair, metabolic alteration, and worse survival in pancreatic ductal adenocarcinoma. Surgery. PMID 31171367 DOI: 10.1016/J.Surg.2019.04.011  0.384
2019 Blundon MA, Dasgupta S. Metabolic dysregulation controls endocrine-therapy resistant cancer recurrence and metastasis. Endocrinology. PMID 31157867 DOI: 10.1210/En.2019-00097  0.532
2019 Dasgupta S, Anand V, John H, Dessai AS, Katsuta E, Takabe K, O'Malley B. Abstract P5-05-01: Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive aggressive metastatic breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P5-05-01  0.468
2019 Katsuta E, Anand V, Yan L, Dasgupta S, Takabe K. Abstract P2-02-04: CD73 expression regulated by estrogen signaling associates with poor prognosis in estrogen receptor (ER)-positive breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P2-02-04  0.423
2019 Katsuta E, Anand V, Yan L, Dasgupta S, Takabe K. Abstract 5200: High CD73 expression, regulated by estrogen signaling, associates with cancer aggressiveness in estrogen receptor (+) breast cancer Cancer Research. 79: 5200-5200. DOI: 10.1158/1538-7445.Am2019-5200  0.441
2018 Singh R, Karri D, Shen H, Shao J, Dasgupta S, Huang S, Edwards DP, Ittmann MM, O'Malley BW, Yi P. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis. The Journal of Clinical Investigation. PMID 29715200 DOI: 10.1172/Jci96060  0.591
2018 Dasgupta S, Rajapakshe K, Zhu B, Nikolai BC, Yi P, Putluri N, Choi JM, Jung SY, Coarfa C, Westbrook TF, Zhang XH, Foulds CE, Tsai SY, Tsai MJ, O'Malley BW. Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature. PMID 29615789 DOI: 10.1038/S41586-018-0018-1  0.434
2018 Katsuta E, Dasgupta S, Yan L, Takabe K. Higher CD73 Expression Is Associated with Poor Prognosis in Estrogen Receptor-Positive Breast Cancer Journal of the American College of Surgeons. 227: S34. DOI: 10.1016/J.Jamcollsurg.2018.07.054  0.384
2017 Dasgupta S, Zhu B, Nikolai B, Putluri N, Foulds C, Tsai S, Tsai M, O'Malley B. Abstract P3-05-01: Increased glycolysis directly activates transcriptional coactivator SRC-3 to promote aggressive metastatic breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P3-05-01  0.441
2016 Kaushik AK, Shojaie A, Panzitt K, Sonavane R, Venghatakrishnan H, Manikkam M, Zaslavsky A, Putluri V, Vasu VT, Zhang Y, Khan AS, Lloyd S, Szafran AT, Dasgupta S, Bader DA, et al. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nature Communications. 7: 11612. PMID 27194471 DOI: 10.1038/Ncomms11612  0.565
2016 Nikolai BC, Lanz RB, York B, Dasgupta S, Mitsiades N, Creighton CJ, Tsimelzon A, Hilsenbeck SG, Lonard DM, Smith CL, O'Malley BW. HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes. Cancer Research. 76: 1463-75. PMID 26833126 DOI: 10.1158/0008-5472.Can-15-2383  0.445
2016 Kaushik AK, Shojaie A, Panzitt K, Sonavane R, Venghatakrishnan H, Manikkam M, Zaslavsky A, Putluri V, Vasu V, Zhang Y, Khan A, Lloyd S, Szafran A, Dasgupta S, Bader D, et al. Abstract 1056: Inhibition of hexose monophosphate pathway promotes castration resistant prostate cancer Cancer Research. 76: 1056-1056. DOI: 10.1158/1538-7445.Am2016-1056  0.489
2015 Jin F, Bhowmik SK, Putluri V, Gu F, Gohlke J, Von Rundstedt FC, Dasgupta S, Krishnapuram R, O'Malley BW, Sreekumar A, Putluri N. A Novel [(15)N] Glutamine Flux using LC-MS/MS-SRM for Determination of Nucleosides and Nucleobases. Journal of Analytical & Bioanalytical Techniques. 6. PMID 27158554 DOI: 10.4172/2155-9872.1000267  0.332
2015 Kpetemey M, Dasgupta S, Rajendiran S, Das S, Gibbs LD, Shetty P, Gryczynski Z, Vishwanatha JK. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression. Molecular Cancer. 14: 156. PMID 26272794 DOI: 10.1186/S12943-015-0428-8  0.605
2015 Rajendiran S, Kpetemey M, Maji S, Gibbs LD, Dasgupta S, Mantsch R, Hare RJ, Vishwanatha JK. MIEN1 promotes oral cancer progression and implicates poor overall survival. Cancer Biology & Therapy. 16: 876-85. PMID 25996585 DOI: 10.1080/15384047.2015.1040962  0.662
2015 Dasgupta S, Putluri N, Long W, Zhang B, Wang J, Kaushik AK, Arnold JM, Bhowmik SK, Stashi E, Brennan CA, Rajapakshe K, Coarfa C, Mitsiades N, Ittmann MM, Chinnaiyan AM, et al. Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis. The Journal of Clinical Investigation. 125: 1174-88. PMID 25664849 DOI: 10.1172/Jci76029  0.572
2015 Kpetemey M, Dasgupta S, Rajendiran S, Das S, Gibbs LD, Shetty P, Gryczynski Z, Vishwanatha JK. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression Molecular Cancer. 14. DOI: 10.1186/s12943-015-0428-8  0.539
2014 Rajendiran S, Parwani AV, Hare RJ, Dasgupta S, Roby RK, Vishwanatha JK. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1. Molecular Cancer. 13: 250. PMID 25406943 DOI: 10.1186/1476-4598-13-250  0.684
2014 Dasgupta S, O'Malley BW. Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology. Journal of Molecular Endocrinology. 53: R47-59. PMID 25024406 DOI: 10.1530/Jme-14-0080  0.334
2014 Dasgupta S, Lonard DM, O'Malley BW. Nuclear receptor coactivators: master regulators of human health and disease. Annual Review of Medicine. 65: 279-92. PMID 24111892 DOI: 10.1146/Annurev-Med-051812-145316  0.332
2012 Dasgupta S, Srinidhi S, Vishwanatha JK. Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges. Journal of Carcinogenesis. 11: 4. PMID 22438770 DOI: 10.4103/1477-3163.93001  0.672
2012 Dasgupta S, Zhang B, Louet J, O'Malley BW. Abstract 5153: Steroid receptor coactivator-2 mediates oncogenic reprogramming of cancer cell metabolism Cancer Research. 72: 5153-5153. DOI: 10.1158/1538-7445.Am2012-5153  0.584
2011 Dasgupta S, Cushman I, Kpetemey M, Casey PJ, Vishwanatha JK. Prenylated c17orf37 induces filopodia formation to promote cell migration and metastasis. The Journal of Biological Chemistry. 286: 25935-46. PMID 21628459 DOI: 10.1074/Jbc.M111.254599  0.621
2010 Das S, Shetty P, Valapala M, Dasgupta S, Gryczynski Z, Vishwanatha JK. Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells. Biochemistry. 49: 2216-26. PMID 20121258 DOI: 10.1021/Bi9013038  0.663
2009 Dasgupta S, Wasson LM, Rauniyar N, Prokai L, Borejdo J, Vishwanatha JK. Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells. Oncogene. 28: 2860-72. PMID 19503095 DOI: 10.1038/Onc.2009.145  0.709
2009 Dasgupta S, Vishwanatha JK. Abstract A9: Importance of C17orf37 prenyl modification in cancer cell migration and invasion Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-A9  0.618
2007 Dasgupta S, Vishwanatha JK. Role of C17orf37/MGC14832 in prostate cancer cell proliferation and migration The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A289-B  0.666
Show low-probability matches.